0001179110-18-013361.txt : 20181203 0001179110-18-013361.hdr.sgml : 20181203 20181203160652 ACCESSION NUMBER: 0001179110-18-013361 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181129 FILED AS OF DATE: 20181203 DATE AS OF CHANGE: 20181203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simonian Nancy A CENTRAL INDEX KEY: 0001359574 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 181214080 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 4 1 edgar.xml FORM 4 - X0306 4 2018-11-29 0 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001359574 Simonian Nancy A C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE, SUITE 300 CAMBRIDGE MA 02139 1 1 0 0 President & CEO Common Stock 2018-11-29 4 M 0 98504 1.01 A 469204 D Common Stock 2018-11-29 4 M 0 12084 3.04 A 481288 D Stock Option (right to buy) 1.01 2018-11-29 4 M 0 23454 0 A 2023-05-21 Common Stock 23454 872657 D Stock Option (right to buy) 1.01 2018-11-29 4 M 0 75050 0 A 2023-05-21 Common Stock 75050 797607 D Stock Option (right to buy) 3.04 2018-11-29 4 M 0 12084 0 A 2024-10-21 Common Stock 12084 785523 D This option is fully vested. /s/ Nancy Simonian 2018-12-03